Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Number of holders
-
30
-
Total 13F shares, excl. options
-
13,820,640
-
Shares change
-
+53,856
-
Total reported value, excl. options
-
$77,390,000
-
Value change
-
+$296,162
-
Number of buys
-
11
-
Number of sells
-
11
-
Price
-
$5.60
Institutional Holders of GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) as of Q3 2015
As of 30 Sep 2015 GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) had 30 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 13,820,640 shares of stock of the company.
Largest 10 holders included NEA Management Company, LLC, WELLINGTON MANAGEMENT GROUP LLP, FRANKLIN RESOURCES INC, Cormorant Asset Management, LLC, Candriam Luxembourg S.C.A., VANGUARD GROUP INC, WALL STREET ASSOCIATES, FMR LLC, DEUTSCHE BANK AG\, and BRIDGEWAY CAPITAL MANAGEMENT INC.
This table shows 30 institutional shareholders of the security as of 30 Sep 2015.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.